{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:34:36Z","timestamp":1791488076249,"version":"4.3.4"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00281-020-00788-y","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T15:03:13Z","timestamp":1583766193000},"page":"247-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Leishmaniasis immunopathology\u2014impact on design and use of vaccines, diagnostics and drugs"],"prefix":"10.1007","volume":"42","author":[{"given":"Paul M.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Van Bocxlaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3902-8006","authenticated-orcid":false,"given":"Simon L.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"issue":"5","key":"788_CR1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7(5):e35671","journal-title":"PLoS One"},{"issue":"10151","key":"788_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/s0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M (2018) Leishmaniasis. Lancet 392(10151):951\u2013970. https:\/\/doi.org\/10.1016\/s0140-6736(18)31204-2","journal-title":"Lancet"},{"issue":"2","key":"788_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","volume":"30","author":"D Mukhopadhyay","year":"2014","unstructured":"Mukhopadhyay D, Dalton JE, Kaye PM, Chatterjee M (2014) Post kala-azar dermal leishmaniasis: an unresolved mystery. Trends Parasitol 30(2):65\u201374. https:\/\/doi.org\/10.1016\/j.pt.2013.12.004","journal-title":"Trends Parasitol"},{"issue":"1","key":"788_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0014-4894(89)90176-8","volume":"69","author":"DL Sacks","year":"1989","unstructured":"Sacks DL (1989) Metacyclogenesis in Leishmania promastigotes. Exp Parasitol 69(1):100\u2013103","journal-title":"Exp Parasitol"},{"key":"788_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1756-3305-5-276","volume":"5","author":"A Dostalova","year":"2012","unstructured":"Dostalova A, Volf P (2012) Leishmania development in sand flies: parasite-vector interactions overview. Parasit Vectors 5:276. https:\/\/doi.org\/10.1186\/1756-3305-5-276","journal-title":"Parasit Vectors"},{"issue":"5","key":"788_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41564-018-0125-7","volume":"3","author":"TD Serafim","year":"2018","unstructured":"Serafim TD, Coutinho-Abreu IV, Oliveira F, Meneses C, Kamhawi S, Valenzuela JG (2018) Sequential blood meals promote Leishmania replication and reverse metacyclogenesis augmenting vector infectivity. Nat Microbiol 3(5):548\u2013555. https:\/\/doi.org\/10.1038\/s41564-018-0125-7","journal-title":"Nat Microbiol"},{"issue":"2","key":"788_CR7","doi-asserted-by":"publisher","first-page":"e1004683","DOI":"10.1371\/journal.ppat.1004683","volume":"11","author":"J Kloehn","year":"2015","unstructured":"Kloehn J, Saunders EC, O\u2019Callaghan S, Dagley MJ, McConville MJ (2015) Characterization of metabolically quiescent Leishmania parasites in murine lesions using heavy water labeling. PLoS Pathog 11(2):e1004683. https:\/\/doi.org\/10.1371\/journal.ppat.1004683","journal-title":"PLoS Pathog"},{"issue":"5","key":"788_CR8","doi-asserted-by":"publisher","first-page":"E801","DOI":"10.1073\/pnas.1619265114","volume":"114","author":"MA Mandell","year":"2017","unstructured":"Mandell MA, Beverley SM (2017) Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts. Proc Natl Acad Sci U S A 114(5):E801\u2013e810. https:\/\/doi.org\/10.1073\/pnas.1619265114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"788_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0020-7519(01)00259-4","volume":"31","author":"RJS Burchmore","year":"2001","unstructured":"Burchmore RJS, Barrett MP (2001) Life in vacuoles \u2013 nutrient acquisition by Leishmania amastigotes. Int J Parasitol 31(12):1311\u20131320. https:\/\/doi.org\/10.1016\/S0020-7519(01)00259-4","journal-title":"Int J Parasitol"},{"key":"788_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1017\/S0031182002001439","volume":"124","author":"ME Rogers","year":"2002","unstructured":"Rogers ME, Chance ML, Bates PA (2002) The role of promastigote secretory gel in the origin and transmission of the infective stage of Leishmania mexicana by the sandfly Lutzomyia longipalpis. Parasitology 124:495\u2013507","journal-title":"Parasitology"},{"key":"788_CR11","doi-asserted-by":"publisher","unstructured":"Giraud E, Svobodova M, Muller I, Volf P, Rogers ME (2019) Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate Leishmania major and Leishmania tropica cutaneous leishmaniasis in mice. Parasitology:1\u20137. https:\/\/doi.org\/10.1017\/s0031182019001069","DOI":"10.1017\/s0031182019001069"},{"issue":"4","key":"788_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/jci116341","volume":"91","author":"C Pirmez","year":"1993","unstructured":"Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F, Modlin RL (1993) Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91(4):1390\u20131395. https:\/\/doi.org\/10.1172\/jci116341","journal-title":"J Clin Invest"},{"issue":"9","key":"788_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","volume":"28","author":"S Nylen","year":"2007","unstructured":"Nylen S, Sacks D (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28(9):378\u2013384. https:\/\/doi.org\/10.1016\/j.it.2007.07.004","journal-title":"Trends Immunol"},{"key":"788_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2334-5-113","volume":"5","author":"A Caldas","year":"2005","unstructured":"Caldas A, Favali C, Aquino D, Vinhas V, van Weyenbergh J, Brodskyn C, Costa J, Barral-Netto M, Barral A (2005) Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 5:113\u2013113. https:\/\/doi.org\/10.1186\/1471-2334-5-113","journal-title":"BMC Infect Dis"},{"issue":"8","key":"788_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","volume":"9","author":"P Kaye","year":"2011","unstructured":"Kaye P, Scott P (2011) Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9(8):604\u2013615","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"788_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol 16(9):581\u2013592. https:\/\/doi.org\/10.1038\/nri.2016.72","journal-title":"Nat Rev Immunol"},{"key":"788_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.12688\/f1000research.11120.1","volume":"6","author":"E Torres-Guerrero","year":"2017","unstructured":"Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R (2017) Leishmaniasis: a review. F1000Research 6:750. https:\/\/doi.org\/10.12688\/f1000research.11120.1","journal-title":"F1000Research"},{"key":"788_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cellimm.2016.07.013","volume":"309","author":"VD Atayde","year":"2016","unstructured":"Atayde VD, Hassani K, da Silva Lira Filho A, Borges AR, Adhikari A, Martel C, Olivier M (2016) Leishmania exosomes and other virulence factors: impact on innate immune response and macrophage functions. Cell Immunol 309:7\u201318. https:\/\/doi.org\/10.1016\/j.cellimm.2016.07.013","journal-title":"Cell Immunol"},{"issue":"11","key":"788_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ni725","volume":"2","author":"T Biedermann","year":"2001","unstructured":"Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, Seegmuller I, Voigt H, Launois P, Levine AD, Wagner H, Heeg K, Louis JA, Rocken M (2001) IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB\/c mice. Nat Immunol 2(11):1054\u20131060. https:\/\/doi.org\/10.1038\/ni725","journal-title":"Nat Immunol"},{"issue":"10","key":"788_CR20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nm933","volume":"9","author":"S Stager","year":"2003","unstructured":"Stager S, Alexander J, Kirby AC, Botto M, Rooijen NV, Smith DF, Brombacher F, Kaye PM (2003) Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med 9(10):1287\u20131292. https:\/\/doi.org\/10.1038\/nm933","journal-title":"Nat Med"},{"key":"788_CR21","doi-asserted-by":"publisher","unstructured":"McFarlane E, Mokgethi T, Kaye PM, Hurdayal R, Brombacher F, Alexander J, Carter KC (2019) IL-4 mediated resistance of BALB\/c mice to visceral Leishmaniasis is independent of IL-4R\u03b1 signaling via T cells. Front Immunol 10(1957). https:\/\/doi.org\/10.3389\/fimmu.2019.01957","DOI":"10.3389\/fimmu.2019.01957"},{"issue":"10","key":"788_CR22","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1002\/1521-4141(200010)30:10<2935::aid-immu2935>3.0.co;2-q","volume":"30","author":"J Alexander","year":"2000","unstructured":"Alexander J, Carter KC, Al-Fasi N, Satoskar A, Brombacher F (2000) Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis. Eur J Immunol 30(10):2935\u20132943. https:\/\/doi.org\/10.1002\/1521-4141(200010)30:10<2935::aid-immu2935>3.0.co;2-q","journal-title":"Eur J Immunol"},{"issue":"3","key":"788_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.chom.2019.08.009","volume":"26","author":"MF Sernee","year":"2019","unstructured":"Sernee MF, Ralton JE, Nero TL, Sobala LF, Kloehn J, Vieira-Lara MA, Cobbold SA, Stanton L, Pires DEV, Hanssen E, Males A, Ward T, Bastidas LM, van der Peet PL, Parker MW, Ascher DB, Williams SJ, Davies GJ, McConville MJ (2019) A family of dual-activity glycosyltransferase-phosphorylases mediates Mannogen turnover and virulence in Leishmania parasites. Cell Host Microbe 26(3):385\u2013399.e389. https:\/\/doi.org\/10.1016\/j.chom.2019.08.009","journal-title":"Cell Host Microbe"},{"issue":"1","key":"788_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, Hume DA, Perlman H, Malissen B, Zelzer E, Jung S (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38(1):79\u201391. https:\/\/doi.org\/10.1016\/j.immuni.2012.12.001","journal-title":"Immunity"},{"issue":"7","key":"788_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nri.2017.42","volume":"17","author":"M Guilliams","year":"2017","unstructured":"Guilliams M, Scott CL (2017) Does niche competition determine the origin of tissue-resident macrophages? Nat Rev Immunol 17(7):451\u2013460. https:\/\/doi.org\/10.1038\/nri.2017.42","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"788_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1084\/jem.20171389","volume":"215","author":"SH Lee","year":"2018","unstructured":"Lee SH, Charmoy M, Romano A, Paun A, Chaves MM, Cope FO, Ralph DA, Sacks DL (2018) Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment. J Exp Med 215(1):357\u2013375. https:\/\/doi.org\/10.1084\/jem.20171389","journal-title":"J Exp Med"},{"issue":"4","key":"788_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jhep.2016.05.037","volume":"65","author":"L Beattie","year":"2016","unstructured":"Beattie L, Sawtell A, Mann J, Frame TCM, Teal B, de Labastida RF, Brown N, Walwyn-Brown K, Moore JWJ, MacDonald S, Lim EK, Dalton JE, Engwerda CR, MacDonald KP, Kaye PM (2016) Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions. J Hepatol 65(4):758\u2013768. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.037","journal-title":"J Hepatol"},{"issue":"10","key":"788_CR28","doi-asserted-by":"publisher","first-page":"e1007374","DOI":"10.1371\/journal.ppat.1007374","volume":"14","author":"S Heyde","year":"2018","unstructured":"Heyde S, Philipsen L, Formaglio P, Fu Y, Baars I, Hobbel G, Kleinholz CL, Seiss EA, Stettin J, Gintschel P, Dudeck A, Bousso P, Schraven B, Muller AJ (2018) CD11c-expressing Ly6C+CCR2+ monocytes constitute a reservoir for efficient Leishmania proliferation and cell-to-cell transmission. PLoS Pathog 14(10):e1007374. https:\/\/doi.org\/10.1371\/journal.ppat.1007374","journal-title":"PLoS Pathog"},{"issue":"6","key":"788_CR29","doi-asserted-by":"publisher","first-page":"e1006479","DOI":"10.1371\/journal.ppat.1006479","volume":"13","author":"A Romano","year":"2017","unstructured":"Romano A, Carneiro MBH, Doria NA, Roma EH, Ribeiro-Gomes FL, Inbar E, Lee SH, Mendez J, Paun A, Sacks DL, Peters NC (2017) Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major. PLoS Pathog 13(6):e1006479. https:\/\/doi.org\/10.1371\/journal.ppat.1006479","journal-title":"PLoS Pathog"},{"issue":"1","key":"788_CR30","doi-asserted-by":"publisher","first-page":"14693","DOI":"10.1038\/s41598-017-14935-3","volume":"7","author":"C Terrazas","year":"2017","unstructured":"Terrazas C, Varikuti S, Oghumu S, Steinkamp HM, Ardic N, Kimble J, Nakhasi H, Satoskar AR (2017) Ly6C(hi) inflammatory monocytes promote susceptibility to Leishmania donovani infection. Sci Rep 7(1):14693. https:\/\/doi.org\/10.1038\/s41598-017-14935-3","journal-title":"Sci Rep"},{"key":"788_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fimmu.2019.00227","volume":"10","author":"R Tiburcio","year":"2019","unstructured":"Tiburcio R, Nunes S, Nunes I, Rosa Ampuero M, Silva IB, Lima R, Machado Tavares N, Brodskyn C (2019) Molecular aspects of dendritic cell activation in Leishmaniasis: an immunobiological view. Front Immunol 10:227. https:\/\/doi.org\/10.3389\/fimmu.2019.00227","journal-title":"Front Immunol"},{"issue":"5","key":"788_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.pt.2016.02.003","volume":"32","author":"BP Hurrell","year":"2016","unstructured":"Hurrell BP, Regli IB, Tacchini-Cottier F (2016) Different Leishmania species drive distinct neutrophil functions. Trends Parasitol 32(5):392\u2013401. https:\/\/doi.org\/10.1016\/j.pt.2016.02.003","journal-title":"Trends Parasitol"},{"issue":"7","key":"788_CR33","doi-asserted-by":"publisher","first-page":"e1006465","DOI":"10.1371\/journal.ppat.1006465","volume":"13","author":"AI Pinto","year":"2017","unstructured":"Pinto AI, Brown N, Preham O, Doehl JSP, Ashwin H, Kaye PM (2017) TNF signalling drives expansion of bone marrow CD4+ T cells responsible for HSC exhaustion in experimental visceral leishmaniasis. PLoS Pathog 13(7):e1006465. https:\/\/doi.org\/10.1371\/journal.ppat.1006465","journal-title":"PLoS Pathog"},{"issue":"8","key":"788_CR34","doi-asserted-by":"publisher","first-page":"e1006422","DOI":"10.1371\/journal.ppat.1006422","volume":"13","author":"BM Abidin","year":"2017","unstructured":"Abidin BM, Hammami A, Stager S, Heinonen KM (2017) Infection-adapted emergency hematopoiesis promotes visceral leishmaniasis. PLoS Pathog 13(8):e1006422. https:\/\/doi.org\/10.1371\/journal.ppat.1006422","journal-title":"PLoS Pathog"},{"issue":"2","key":"788_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00281-015-0548-7","volume":"38","author":"PM Kaye","year":"2016","unstructured":"Kaye PM, Beattie L (2016) Lessons from other diseases: granulomatous inflammation in leishmaniasis. Semin Immunopathol 38(2):249\u2013260. https:\/\/doi.org\/10.1007\/s00281-015-0548-7","journal-title":"Semin Immunopathol"},{"issue":"2","key":"788_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0163-4453(98)80007-8","volume":"36","author":"G Angarano","year":"1998","unstructured":"Angarano G, Maggi P, Rollo MA, Larocca AM, Quarto M, Scalone A, Gradoni L (1998) Diffuse necrotic hepatic lesions due to visceral leishmaniasis in AIDS. J infect 36(2):167\u2013169. https:\/\/doi.org\/10.1016\/s0163-4453(98)80007-8","journal-title":"J infect"},{"issue":"1","key":"788_CR37","first-page":"12","volume":"32","author":"P Yazici","year":"2008","unstructured":"Yazici P, Yeniay L, Aydin U, Tasbakan M, Ozutemiz O, Yilmaz R (2008) Visceral leishmaniasis as a rare cause of granulomatosis hepatitis: a case report. Turkiye parazitolojii dergisi 32(1):12\u201315","journal-title":"Turkiye parazitolojii dergisi"},{"key":"788_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1051\/parasite\/2019007","volume":"26","author":"T Boussoffara","year":"2019","unstructured":"Boussoffara T, Boubaker MS, Ben Ahmed M, Mokni M, Guizani I, Ben Salah A, Louzir H (2019) Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum. Parasite (Paris, France) 26:9. https:\/\/doi.org\/10.1051\/parasite\/2019007","journal-title":"Parasite (Paris, France)"},{"issue":"5","key":"788_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/iep.12295","volume":"99","author":"CM Sandoval Pacheco","year":"2018","unstructured":"Sandoval Pacheco CM, Araujo Flores GV, Favero Ferreira A, Sosa Ochoa W, Ribeiro da Matta VL, Zuniga Valeriano C, Pereira Corbett CE, Dalastra Laurenti M (2018) Histopathological features of skin lesions in patients affected by non-ulcerated or atypical cutaneous leishmaniasis in Honduras, Central America. Int J Exp Pathol 99(5):249\u2013257. https:\/\/doi.org\/10.1111\/iep.12295","journal-title":"Int J Exp Pathol"},{"issue":"8","key":"788_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/dad.0000000000001367","volume":"41","author":"IK Thilakarathne","year":"2019","unstructured":"Thilakarathne IK, Ratnayake P, Vithanage A, Sugathadasa DP (2019) Role of histopathology in the diagnosis of cutaneous Leishmaniasis: a case-control study in Sri Lanka. Am J Dermatopathol 41(8):566\u2013570. https:\/\/doi.org\/10.1097\/dad.0000000000001367","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"788_CR41","doi-asserted-by":"publisher","first-page":"e2853","DOI":"10.1371\/journal.pntd.0002853","volume":"8","author":"G Grimaldi Jr","year":"2014","unstructured":"Grimaldi G Jr, Teva A, Porrozzi R, Pinto MA, Marchevsky RS, Rocha MG, Dutra MS, Bruna-Romero O, Fernandes AP, Gazzinelli RT (2014) Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen. PLoS Negl Trop Dis 8(6):e2853. https:\/\/doi.org\/10.1371\/journal.pntd.0002853","journal-title":"PLoS Negl Trop Dis"},{"issue":"28","key":"788_CR42","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","volume":"23","author":"A Khamesipour","year":"2005","unstructured":"Khamesipour A, Dowlati Y, Asilian A, Hashemi-Fesharki R, Javadi A, Noazin S, Modabber F (2005) Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine 23(28):3642\u20133648. https:\/\/doi.org\/10.1016\/j.vaccine.2005.02.015","journal-title":"Vaccine"},{"issue":"8","key":"788_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5(8):606\u2013616. https:\/\/doi.org\/10.1038\/nri1669","journal-title":"Nat Rev Immunol"},{"key":"788_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-319-78127-3_2","volume":"1060","author":"PM Kaye","year":"2018","unstructured":"Kaye PM (2018) Stromal cell responses in infection. Adv Exp Med Biol 1060:23\u201336. https:\/\/doi.org\/10.1007\/978-3-319-78127-3_2","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"788_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.icb7100011","volume":"85","author":"AC Stanley","year":"2007","unstructured":"Stanley AC, Engwerda CR (2007) Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85(2):138\u2013147. https:\/\/doi.org\/10.1038\/sj.icb7100011","journal-title":"Immunol Cell Biol"},{"key":"788_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fcimb.2018.00394","volume":"8","author":"MD Hermida","year":"2018","unstructured":"Hermida MD, de Melo CVB, Lima IDS, Oliveira GGS, Dos-Santos WLC (2018) Histological disorganization of spleen compartments and severe visceral Leishmaniasis. Front Cell Infect Microbiol 8:394. https:\/\/doi.org\/10.3389\/fcimb.2018.00394","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"788_CR47","doi-asserted-by":"publisher","first-page":"e0005123","DOI":"10.1371\/journal.pntd.0005123","volume":"10","author":"LG Gardinassi","year":"2016","unstructured":"Gardinassi LG, Garcia GR, Costa CH, Costa Silva V, de Miranda Santos IK (2016) Blood transcriptional profiling reveals immunological signatures of distinct states of infection of humans with Leishmania infantum. PLoS Negl Trop Dis 10(11):e0005123. https:\/\/doi.org\/10.1371\/journal.pntd.0005123","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"788_CR48","doi-asserted-by":"publisher","first-page":"e0007673","DOI":"10.1371\/journal.pntd.0007673","volume":"13","author":"M Fakiola","year":"2019","unstructured":"Fakiola M, Singh OP, Syn G, Singh T, Singh B, Chakravarty J, Sundar S, Blackwell JM (2019) Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India. PLoS Negl Trop Dis 13(8):e0007673. https:\/\/doi.org\/10.1371\/journal.pntd.0007673","journal-title":"PLoS Negl Trop Dis"},{"key":"788_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.12688\/wellcomeopenres.14867.2","volume":"3","author":"H Ashwin","year":"2018","unstructured":"Ashwin H, Seifert K, Forrester S, Brown N, MacDonald S, James S, Lagos D, Timmis J, Mottram JC, Croft SL, Kaye PM (2018) Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis. Wellcome Open Research 3:135. https:\/\/doi.org\/10.12688\/wellcomeopenres.14867.2","journal-title":"Wellcome Open Research"},{"issue":"1","key":"788_CR50","doi-asserted-by":"publisher","first-page":"e1006165","DOI":"10.1371\/journal.ppat.1006165","volume":"13","author":"F Kong","year":"2017","unstructured":"Kong F, Saldarriaga OA, Spratt H, Osorio EY, Travi BL, Luxon BA, Melby PC (2017) Transcriptional profiling in experimental visceral Leishmaniasis reveals a broad splenic inflammatory environment that conditions macrophages toward a disease-promoting phenotype. PLoS Pathog 13(1):e1006165. https:\/\/doi.org\/10.1371\/journal.ppat.1006165","journal-title":"PLoS Pathog"},{"issue":"1","key":"788_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s0036-46652014000100001","volume":"56","author":"EN Loria-Cervera","year":"2014","unstructured":"Loria-Cervera EN, Andrade-Narvaez FJ (2014) Animal models for the study of leishmaniasis immunology. Rev Inst Med Trop Sao Paulo 56(1):1\u201311. https:\/\/doi.org\/10.1590\/s0036-46652014000100001","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"788_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fimmu.2012.00301","volume":"3","author":"LP Carvalho","year":"2012","unstructured":"Carvalho LP, Passos S, Schriefer A, Carvalho EM (2012) Protective and pathologic immune responses in human tegumentary leishmaniasis. Front Immunol 3:301. https:\/\/doi.org\/10.3389\/fimmu.2012.00301","journal-title":"Front Immunol"},{"issue":"6018","key":"788_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1126\/science.1199326","volume":"331","author":"A Ives","year":"2011","unstructured":"Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, Schutz F, Zangger H, Revaz-Breton M, Lye LF, Hickerson SM, Beverley SM, Acha-Orbea H, Launois P, Fasel N, Masina S (2011) Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science (New York, NY) 331(6018):775\u2013778. https:\/\/doi.org\/10.1126\/science.1199326","journal-title":"Science (New York, NY)"},{"issue":"2","key":"788_CR54","doi-asserted-by":"publisher","first-page":"e1006196","DOI":"10.1371\/journal.ppat.1006196","volume":"13","author":"FO Novais","year":"2017","unstructured":"Novais FO, Carvalho AM, Clark ML, Carvalho LP, Beiting DP, Brodsky IE, Carvalho EM, Scott P (2017) CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1beta production. PLoS Pathog 13(2):e1006196. https:\/\/doi.org\/10.1371\/journal.ppat.1006196","journal-title":"PLoS Pathog"},{"issue":"19","key":"788_CR55","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1073\/pnas.1621447114","volume":"114","author":"M Rossi","year":"2017","unstructured":"Rossi M, Castiglioni P, Hartley MA, Eren RO, Prevel F, Desponds C, Utzschneider DT, Zehn D, Cusi MG, Kuhlmann FM, Beverley SM, Ronet C, Fasel N (2017) Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis. Proc Natl Acad Sci U S A 114(19):4987\u20134992. https:\/\/doi.org\/10.1073\/pnas.1621447114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"788_CR56","doi-asserted-by":"publisher","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","volume":"31","author":"J Alvar","year":"2013","unstructured":"Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG (2013) Case study for a vaccine against leishmaniasis. Vaccine 31(Suppl 2):B244\u2013B249. https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.080","journal-title":"Vaccine"},{"issue":"Suppl","key":"788_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/hv.7.0.14556","volume":"7","author":"J Schroeder","year":"2011","unstructured":"Schroeder J, Aebischer T (2011) Vaccines for leishmaniasis: from proteome to vaccine candidates. Hum Vaccin 7(Suppl):10\u201315. https:\/\/doi.org\/10.4161\/hv.7.0.14556","journal-title":"Hum Vaccin"},{"issue":"7","key":"788_CR58","doi-asserted-by":"publisher","first-page":"e1721","DOI":"10.1371\/journal.pntd.0001721","volume":"6","author":"A Masic","year":"2012","unstructured":"Masic A, Hurdayal R, Nieuwenhuizen NE, Brombacher F, Moll H (2012) Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB\/c mice. PLoS Negl Trop Dis 6(7):e1721. https:\/\/doi.org\/10.1371\/journal.pntd.0001721","journal-title":"PLoS Negl Trop Dis"},{"key":"788_CR59","doi-asserted-by":"publisher","unstructured":"Majumder S, Bhattacharjee A, Paul Chowdhury B, Bhattacharyya Majumdar S, Majumdar S (2014) Antigen-pulsed CpG-ODN-activated dendritic cells induce host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice: critical role of CXCL10. Front Immunol 5(261). https:\/\/doi.org\/10.3389\/fimmu.2014.00261","DOI":"10.3389\/fimmu.2014.00261"},{"issue":"11","key":"788_CR60","doi-asserted-by":"publisher","first-page":"e0005951","DOI":"10.1371\/journal.pntd.0005951","volume":"11","author":"P Cecilio","year":"2017","unstructured":"Cecilio P, Perez-Cabezas B, Fernandez L, Moreno J, Carrillo E, Requena JM, Fichera E, Reed SG, Coler RN, Kamhawi S, Oliveira F, Valenzuela JG, Gradoni L, Glueck R, Gupta G, Cordeiro-da-Silva A (2017) Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis. PLoS Negl Trop Dis 11(11):e0005951. https:\/\/doi.org\/10.1371\/journal.pntd.0005951","journal-title":"PLoS Negl Trop Dis"},{"issue":"234","key":"788_CR61","doi-asserted-by":"publisher","first-page":"234ra256","DOI":"10.1126\/scitranslmed.3008222","volume":"6","author":"S Das","year":"2014","unstructured":"Das S, Freier A, Boussoffara T, Das S, Oswald D, Losch FO, Selka M, Sacerdoti-Sierra N, Schonian G, Wiesmuller KH, Seifert K, Schroff M, Juhls C, Jaffe CL, Roy S, Das P, Louzir H, Croft SL, Modabber F, Walden P (2014) Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci Transl Med 6(234):234ra256. https:\/\/doi.org\/10.1126\/scitranslmed.3008222","journal-title":"Sci Transl Med"},{"issue":"5","key":"788_CR62","doi-asserted-by":"publisher","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","volume":"11","author":"M Osman","year":"2017","unstructured":"Osman M, Mistry A, Keding A, Gabe R, Cook E, Forrester S, Wiggins R, Di Marco S, Colloca S, Siani L, Cortese R, Smith DF, Aebischer T, Kaye PM, Lacey CJ (2017) A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH. PLoS Negl Trop Dis 11(5):e0005527. https:\/\/doi.org\/10.1371\/journal.pntd.0005527","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"788_CR63","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1038\/s41598-017-05088-4","volume":"7","author":"S Gannavaram","year":"2017","unstructured":"Gannavaram S, Torcivia J, Gasparyan L, Kaul A, Ismail N, Simonyan V, Nakhasi HL (2017) Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization. Sci Rep 7(1):4718. https:\/\/doi.org\/10.1038\/s41598-017-05088-4","journal-title":"Sci Rep"},{"issue":"5","key":"788_CR64","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/infdis\/jir842","volume":"205","author":"A Maroof","year":"2012","unstructured":"Maroof A, Brown N, Smith B, Hodgkinson MR, Maxwell A, Losch FO, Fritz U, Walden P, Lacey CN, Smith DF, Aebischer T, Kaye PM (2012) Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. J Infect Dis 205(5):853\u2013863. https:\/\/doi.org\/10.1093\/infdis\/jir842","journal-title":"J Infect Dis"},{"issue":"43","key":"788_CR65","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.1016\/j.vaccine.2018.08.087","volume":"36","author":"A Toepp","year":"2018","unstructured":"Toepp A, Larson M, Wilson G, Grinnage-Pulley T, Bennett C, Leal-Lima A, Anderson B, Parrish M, Anderson M, Fowler H, Hinman J, Kontowicz E, Jefferies J, Beeman M, Buch J, Saucier J, Tyrrell P, Gharpure R, Cotter C, Petersen C (2018) Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis. Vaccine 36(43):6433\u20136441. https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.087","journal-title":"Vaccine"},{"key":"788_CR66","unstructured":"WHO (2016) Leishmaniasis in high-burden countries: An epidemiological update based on data reported in 2014 WHO Weekly epidemiological record 22 (91):285\u2013296"},{"key":"788_CR67","unstructured":"Organization WECotCotLWH (2010) Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of Leishmaniases vol 949. World Health Organization, Geneva"},{"issue":"2","key":"788_CR68","first-page":"318","volume":"40","author":"AC Ghose","year":"1980","unstructured":"Ghose AC, Haldar JP, Pal SC, Mishra BP, Mishra KK (1980) Serological investigations on Indian kala-azar. Clin Exp Immunol 40(2):318\u2013326","journal-title":"Clin Exp Immunol"},{"key":"788_CR69","doi-asserted-by":"publisher","unstructured":"Boelaert M, Verdonck K, Menten J, Sunyoto T, van Griensven J, Chappuis F, Rijal S (2014) Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. The Cochrane database of systematic reviews (6):Cd009135. https:\/\/doi.org\/10.1002\/14651858.CD009135.pub2","DOI":"10.1002\/14651858.CD009135.pub2"},{"issue":"11","key":"788_CR70","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","volume":"5","author":"F Chappuis","year":"2007","unstructured":"Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5(11):873\u2013882","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"788_CR71","doi-asserted-by":"publisher","first-page":"e2057","DOI":"10.1371\/journal.pntd.0002057","volume":"7","author":"T Bhattacharyya","year":"2013","unstructured":"Bhattacharyya T, Boelaert M, Miles MA (2013) Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms. PLoS Negl Trop Dis 7(2):e2057. https:\/\/doi.org\/10.1371\/journal.pntd.0002057","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"788_CR72","doi-asserted-by":"publisher","first-page":"e2675","DOI":"10.1371\/journal.pntd.0002675","volume":"8","author":"T Bhattacharyya","year":"2014","unstructured":"Bhattacharyya T, Bowes DE, El-Safi S, Sundar S, Falconar AK, Singh OP, Kumar R, Ahmed O, Boelaert M, Miles MA (2014) Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis. PLoS Negl Trop Dis 8(2):e2675. https:\/\/doi.org\/10.1371\/journal.pntd.0002675","journal-title":"PLoS Negl Trop Dis"},{"key":"788_CR73","doi-asserted-by":"publisher","unstructured":"Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, Guderian JA, Colombara D, Abdoon AO, Mukhtar MM, Mondal D, Esfandiari J, Kumar S, Chun P, Reed SG, Bhatia A (2010) Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis 4(9). https:\/\/doi.org\/10.1371\/journal.pntd.0000822","DOI":"10.1371\/journal.pntd.0000822"},{"issue":"6","key":"788_CR74","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.4269\/ajtmh.13-0759","volume":"91","author":"A Bezuneh","year":"2014","unstructured":"Bezuneh A, Mukhtar M, Abdoun A, Teferi T, Takele Y, Diro E, Jemaneh A, Shiferaw W, Wondimu H, Bhatia A, Howard RF, Ghalib H, Ireton GC, Hailu A, Reed SG (2014) Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients. Am J Trop Med Hyg 91(6):1109\u20131115. https:\/\/doi.org\/10.4269\/ajtmh.13-0759","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"788_CR75","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/trstmh\/trv060","volume":"109","author":"M Mukhtar","year":"2015","unstructured":"Mukhtar M, Abdoun A, Ahmed AE, Ghalib H, Reed SG, Boelaert M, Menten J, Khair MM, Howard RF (2015) Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan. Trans R Soc Trop Med Hyg 109(9):594\u2013600. https:\/\/doi.org\/10.1093\/trstmh\/trv060","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"788_CR76","doi-asserted-by":"publisher","first-page":"e0006264","DOI":"10.1371\/journal.pntd.0006264","volume":"12","author":"M Mukhtar","year":"2018","unstructured":"Mukhtar M, Ali SS, Boshara SA, Albertini A, Monnerat S, Bessell P, Mori Y, Kubota Y, Ndung'u JM, Cruz I (2018) Sensitive and less invasive confirmatory diagnosis of visceral leishmaniasis in Sudan using loop-mediated isothermal amplification (LAMP). PLoS Negl Trop Dis 12(2):e0006264. https:\/\/doi.org\/10.1371\/journal.pntd.0006264","journal-title":"PLoS Negl Trop Dis"},{"issue":"13","key":"788_CR77","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1017\/s0031182018000860","volume":"145","author":"KS Subramaniam","year":"2018","unstructured":"Subramaniam KS, Austin V, Schocker NS, Montoya AL, Anderson MS, Ashmus RA, Mesri M, Al-Salem W, Almeida IC, Michael K, Acosta-Serrano A (2018) Anti-alpha-Gal antibodies detected by novel neoglycoproteins as a diagnostic tool for Old World cutaneous leishmaniasis caused by Leishmania major. Parasitology 145(13):1758\u20131764. https:\/\/doi.org\/10.1017\/s0031182018000860","journal-title":"Parasitology"},{"issue":"8","key":"788_CR78","doi-asserted-by":"publisher","first-page":"e3021","DOI":"10.1371\/journal.pntd.0003021","volume":"8","author":"B Monge-Maillo","year":"2014","unstructured":"Monge-Maillo B, Norman FF, Cruz I, Alvar J, Lopez-Velez R (2014) Visceral leishmaniasis and HIV coinfection in the Mediterranean region. PLoS Negl Trop Dis 8(8):e3021. https:\/\/doi.org\/10.1371\/journal.pntd.0003021","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"788_CR79","doi-asserted-by":"publisher","first-page":"e2869","DOI":"10.1371\/journal.pntd.0002869","volume":"8","author":"E Diro","year":"2014","unstructured":"Diro E, Lynen L, Ritmeijer K, Boelaert M, Hailu A, van Griensven J (2014) Visceral Leishmaniasis and HIV coinfection in East Africa. PLoS Negl Trop Dis 8(6):e2869. https:\/\/doi.org\/10.1371\/journal.pntd.0002869","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"788_CR80","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/cvi.00473-10","volume":"18","author":"K Gidwani","year":"2011","unstructured":"Gidwani K, Picado A, Ostyn B, Singh SP, Kumar R, Khanal B, Lejon V, Chappuis F, Boelaert M, Sundar S (2011) Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol 18(2):346\u2013348. https:\/\/doi.org\/10.1128\/cvi.00473-10","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"788_CR81","doi-asserted-by":"publisher","first-page":"e3273","DOI":"10.1371\/journal.pntd.0003273","volume":"8","author":"T Bhattacharyya","year":"2014","unstructured":"Bhattacharyya T, Ayandeh A, Falconar AK, Sundar S, El-Safi S, Gripenberg MA, Bowes DE, Thunissen C, Singh OP, Kumar R, Ahmed O, Eisa O, Saad A, Silva Pereira S, Boelaert M, Mertens P, Miles MA (2014) IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test. PLoS Negl Trop Dis 8(10):e3273. https:\/\/doi.org\/10.1371\/journal.pntd.0003273","journal-title":"PLoS Negl Trop Dis"},{"key":"788_CR82","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fcimb.2018.00427","volume":"8","author":"T Marlais","year":"2018","unstructured":"Marlais T, Bhattacharyya T, Singh OP, Mertens P, Gilleman Q, Thunissen C, Hinckel BCB, Pearson C, Gardner BL, Airs S, de la Roche M, Hayes K, Hafezi H, Falconar AK, Eisa O, Saad A, Khanal B, Bhattarai NR, Rijal S, Boelaert M, El-Safi S, Sundar S, Miles MA (2018) Visceral Leishmaniasis IgG1 rapid monitoring of cure vs. relapse, and potential for diagnosis of post kala-azar dermal Leishmaniasis. Front Cell Infect Microbiol 8:427. https:\/\/doi.org\/10.3389\/fcimb.2018.00427","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"788_CR83","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/cid\/ciy1062","volume":"69","author":"G Mollett","year":"2019","unstructured":"Mollett G, Bremer Hinckel BC, Bhattacharyya T, Marlais T, Singh OP, Mertens P, Falconar AK, El-Safi S, Sundar S, Miles MA (2019) Detection of immunoglobulin G1 against rK39 improves monitoring of treatment outcomes in visceral Leishmaniasis. Clin Infect Dis 69(7):1130\u20131135. https:\/\/doi.org\/10.1093\/cid\/ciy1062","journal-title":"Clin Infect Dis"},{"issue":"4","key":"788_CR84","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/0035-9203(87)90414-7","volume":"81","author":"J Kohanteb","year":"1987","unstructured":"Kohanteb J, Ardehali SM, Rezai HR (1987) Detection of Leishmania donovani soluble antigen and antibody in the urine of visceral leishmaniasis patients. Trans R Soc Trop Med Hyg 81(4):578\u2013580. https:\/\/doi.org\/10.1016\/0035-9203(87)90414-7","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"788_CR85","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4269\/ajtmh.1995.52.427","volume":"52","author":"M De Colmenares","year":"1995","unstructured":"De Colmenares M, Portus M, Riera C, Gallego M, Aisa MJ, Torras S, Munoz C (1995) Short report: detection of 72-75-kD and 123-kD fractions of Leishmania antigen in urine of patients with visceral leishmaniasis. Am J Trop Med Hyg 52(5):427\u2013428. https:\/\/doi.org\/10.4269\/ajtmh.1995.52.427","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"788_CR86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/00034983.1997.11813125","volume":"91","author":"AA Azazy","year":"1997","unstructured":"Azazy AA, Chance ML, Devaney E (1997) A time-course study of circulating antigen and parasite-specific antibody in cotton rats infected with Leishmania donovani. Ann Trop Med Parasitol 91(2):153\u2013162. https:\/\/doi.org\/10.1080\/00034983.1997.11813125","journal-title":"Ann Trop Med Parasitol"},{"key":"788_CR87","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12879-015-1125-3","volume":"15","author":"AC Vallur","year":"2015","unstructured":"Vallur AC, Tutterrow YL, Mohamath R, Pattabhi S, Hailu A, Abdoun AO, Ahmed AE, Mukhtar M, Salam MA, Almeida ML, Almeida RP, Mondal D, Albertini A, Ghalib H, Duthie MS, Reed SG (2015) Development and comparative evaluation of two antigen detection tests for visceral Leishmaniasis. BMC Infect Dis 15:384. https:\/\/doi.org\/10.1186\/s12879-015-1125-3","journal-title":"BMC Infect Dis"},{"issue":"6","key":"788_CR88","doi-asserted-by":"publisher","first-page":"e0003902","DOI":"10.1371\/journal.pntd.0003902","volume":"9","author":"CH Gao","year":"2015","unstructured":"Gao CH, Yang YT, Shi F, Wang JY, Steverding D, Wang X (2015) Development of an Immunochromatographic test for diagnosis of visceral Leishmaniasis based on detection of a circulating antigen. PLoS Negl Trop Dis 9(6):e0003902. https:\/\/doi.org\/10.1371\/journal.pntd.0003902","journal-title":"PLoS Negl Trop Dis"},{"key":"788_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2019.e00103","volume":"5","author":"I Cruz","year":"2019","unstructured":"Cruz I, Albertini A, Barbeitas M, Arana B, Picado A, Ruiz-Postigo JA, Ndung'u JM (2019) Target product profile for a point-of-care diagnostic test for dermal leishmaniases. Parasite Epidemiol Control 5:e00103. https:\/\/doi.org\/10.1016\/j.parepi.2019.e00103","journal-title":"Parasite Epidemiol Control"},{"key":"788_CR90","unstructured":"Ben Salah A, Zaatour A, Gharbi A, Bettaieb J, Ghawar W, Khedher a Clinical evaluation of CL detect TM rapid test for cutaneous leishmaniasis: performance characteristics when compared to smear microscopy at multiple test sites. In: ASTMH, New Orleans, 2014"},{"issue":"3","key":"788_CR91","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4269\/ajtmh.18-0066","volume":"99","author":"I Bennis","year":"2018","unstructured":"Bennis I, Verdonck K, El Khalfaoui N, Riyad M, Fellah H, Dujardin JC, Sahibi H, Bouhout S, Van der Auwera G, Boelaert M (2018) Accuracy of a rapid diagnostic test based on antigen detection for the diagnosis of cutaneous Leishmaniasis in patients with suggestive skin lesions in Morocco. Am J Trop Med Hyg 99(3):716\u2013722. https:\/\/doi.org\/10.4269\/ajtmh.18-0066","journal-title":"Am J Trop Med Hyg"},{"key":"788_CR92","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ebiom.2018.10.063","volume":"37","author":"MMT Vink","year":"2018","unstructured":"Vink MMT, Nahzat SM, Rahimi H, Buhler C, Ahmadi BA, Nader M, Zazai FR, Yousufzai AS, van Loenen M, Schallig H, Picado A, Cruz I (2018) Evaluation of point-of-care tests for cutaneous leishmaniasis diagnosis in Kabul, Afghanistan. EBioMedicine 37:453\u2013460. https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.063","journal-title":"EBioMedicine"},{"issue":"9","key":"788_CR93","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1128\/jcm.00372-14","volume":"52","author":"CM de Ruiter","year":"2014","unstructured":"de Ruiter CM, van der Veer C, Leeflang MM, Deborggraeve S, Lucas C, Adams ER (2014) Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy. J Clin Microbiol 52(9):3147\u20133155. https:\/\/doi.org\/10.1128\/jcm.00372-14","journal-title":"J Clin Microbiol"},{"issue":"2","key":"788_CR94","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1128\/jcm.40.2.601-606.2002","volume":"40","author":"KA Weigle","year":"2002","unstructured":"Weigle KA, Labrada LA, Lozano C, Santrich C, Barker DC (2002) PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). J Clin Microbiol 40(2):601\u2013606. https:\/\/doi.org\/10.1128\/jcm.40.2.601-606.2002","journal-title":"J Clin Microbiol"},{"issue":"5","key":"788_CR95","doi-asserted-by":"publisher","first-page":"895","DOI":"10.4269\/ajtmh.13-0582","volume":"91","author":"F Eroglu","year":"2014","unstructured":"Eroglu F, Uzun S, Koltas IS (2014) Comparison of clinical samples and methods in chronic cutaneous leishmaniasis. Am J Tropical Med Hyg 91(5):895\u2013900. https:\/\/doi.org\/10.4269\/ajtmh.13-0582","journal-title":"Am J Tropical Med Hyg"},{"issue":"11","key":"788_CR96","doi-asserted-by":"publisher","first-page":"e0007698","DOI":"10.1371\/journal.pntd.0007698","volume":"13","author":"CO Nzelu","year":"2019","unstructured":"Nzelu CO, Kato H, Peters NC (2019) Loop-mediated isothermal amplification (LAMP): an advanced molecular point-of-care technique for the detection of Leishmania infection. PLoS Negl Trop Dis 13(11):e0007698. https:\/\/doi.org\/10.1371\/journal.pntd.0007698","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"788_CR97","doi-asserted-by":"publisher","first-page":"e0007616","DOI":"10.1371\/journal.pntd.0007616","volume":"13","author":"A Selvapandiyan","year":"2019","unstructured":"Selvapandiyan A, Croft SL, Rijal S, Nakhasi HL, Ganguly NK (2019) Innovations for the elimination and control of visceral leishmaniasis. PLoS Negl Trop Dis 13(9):e0007616. https:\/\/doi.org\/10.1371\/journal.pntd.0007616","journal-title":"PLoS Negl Trop Dis"},{"key":"788_CR98","volume-title":"Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases","author":"WHO","year":"2017","unstructured":"WHO (2017) Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases. World Health Organisation,"},{"key":"788_CR99","doi-asserted-by":"publisher","first-page":"k5224","DOI":"10.1136\/bmj.k5224","volume":"364","author":"S Rijal","year":"2019","unstructured":"Rijal S, Sundar S, Mondal D, Das P, Alvar J, Boelaert M (2019) Eliminating visceral leishmaniasis in South Asia: the road ahead. BMJ (Clinical research ed) 364:k5224. https:\/\/doi.org\/10.1136\/bmj.k5224","journal-title":"BMJ (Clinical research ed)"},{"issue":"7580","key":"788_CR100","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1038\/nature16042","volume":"528","author":"GF Medley","year":"2015","unstructured":"Medley GF, Hollingsworth TD, Olliaro PL, Adams ER (2015) Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent. Nature 528(7580):S102\u2013S108. https:\/\/doi.org\/10.1038\/nature16042\nhttp:\/\/www.nature.com\/nature\/journal\/v528\/n7580_supp_custom\/abs\/nature16042.html#supplementary-information","journal-title":"Nature"},{"issue":"6","key":"788_CR101","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-3156.2004.01251.x","volume":"9","author":"S Rijal","year":"2004","unstructured":"Rijal S, Boelaert M, Regmi S, Karki BM, Jacquet D, Singh R, Chance ML, Chappuis F, Hommel M, Desjeux P, Van der Stuyft P, Le Ray D, Koirala S (2004) Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health 9(6):724\u2013729. https:\/\/doi.org\/10.1111\/j.1365-3156.2004.01251.x","journal-title":"Trop Med Int Health"},{"issue":"5","key":"788_CR102","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.trstmh.2010.12.007","volume":"105","author":"MA Salam","year":"2011","unstructured":"Salam MA, Khan MG, Mondal D (2011) Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis. Trans R Soc Trop Med Hyg 105(5):269\u2013272. https:\/\/doi.org\/10.1016\/j.trstmh.2010.12.007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"788_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0001-706x(00)00155-8","volume":"78","author":"ZJ Attar","year":"2001","unstructured":"Attar ZJ, Chance ML, el-Safi S, Carney J, Azazy A, El-Hadi M, Dourado C, Hommel M (2001) Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop 78(1):11\u201316. https:\/\/doi.org\/10.1016\/s0001-706x(00)00155-8","journal-title":"Acta Trop"},{"key":"788_CR104","doi-asserted-by":"publisher","unstructured":"Picado A, Cruz I, Sampath R, Ndung'u JM (2019) An antigen detecting rapid diagnostic test (RDT) to accelerate control and elimination of visceral leishmaniasis. 11th European congress on tropical medicine and international health 113. https:\/\/doi.org\/10.1093\/trstmh\/trz0","DOI":"10.1093\/trstmh\/trz0"},{"issue":"Suppl 1","key":"788_CR105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1179\/000349803225002516","volume":"97","author":"R Molina","year":"2003","unstructured":"Molina R, Gradoni L, Alvar J (2003) HIV and the transmission of Leishmania. Ann Trop Med Parasitol 97(Suppl 1):29\u201345. https:\/\/doi.org\/10.1179\/000349803225002516","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"788_CR106","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/cid\/cix245","volume":"65","author":"R Molina","year":"2017","unstructured":"Molina R, Ghosh D, Carrillo E, Monnerat S, Bern C, Mondal D, Alvar J (2017) Infectivity of post-kala-azar dermal Leishmaniasis patients to sand flies: revisiting a proof of concept in the context of the kala-azar elimination program in the Indian subcontinent. Clin Infect Dis 65(1):150\u2013153. https:\/\/doi.org\/10.1093\/cid\/cix245","journal-title":"Clin Infect Dis"},{"key":"788_CR107","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fcimb.2019.00228","volume":"9","author":"EE Zijlstra","year":"2019","unstructured":"Zijlstra EE (2019) Biomarkers in post-kala-azar dermal Leishmaniasis. Front Cell Infect Microbiol 9:228. https:\/\/doi.org\/10.3389\/fcimb.2019.00228","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"788_CR108","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.diagmicrobio.2013.01.011","volume":"75","author":"S Verma","year":"2013","unstructured":"Verma S, Avishek K, Sharma V, Negi NS, Ramesh V, Salotra P (2013) Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis. Diagn Microbiol Infect Dis 75(4):390\u2013395. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.01.011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"788_CR109","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/eji.201847917","volume":"49","author":"S Silva-Barrios","year":"2019","unstructured":"Silva-Barrios S, Stager S (2019) Hypergammaglobulinemia sustains the development of regulatory responses during chronic Leishmania donovani infection in mice. Eur J Immunol 49(7):1082\u20131091. https:\/\/doi.org\/10.1002\/eji.201847917","journal-title":"Eur J Immunol"},{"key":"788_CR110","doi-asserted-by":"publisher","unstructured":"da Silva Junior GB, Guard\u00e3o Barros EJ, De Francesco DE (2014) Kidney involvement in leishmaniasis\u2014a review. Braz J Infect Dis 18(4):434\u2013440. https:\/\/doi.org\/10.1016\/j.bjid.2013.11.013","DOI":"10.1016\/j.bjid.2013.11.013"},{"issue":"6","key":"788_CR111","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1053\/j.gastro.2008.12.073","volume":"136","author":"JP Cello","year":"2009","unstructured":"Cello JP, Day LW (2009) Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology 136(6):1952\u20131965. https:\/\/doi.org\/10.1053\/j.gastro.2008.12.073","journal-title":"Gastroenterology"},{"issue":"1","key":"788_CR112","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","volume":"96","author":"N Aronson","year":"2017","unstructured":"Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho E, Ephros M, Jeronimo S, Magill A (2017) Diagnosis and treatment of Leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Tropical Med Hyg 96(1):24\u201345. https:\/\/doi.org\/10.4269\/ajtmh.16-84256","journal-title":"Am J Tropical Med Hyg"},{"key":"788_CR113","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/14651858.CD005067.pub3","volume":"4","author":"U Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez U, Pinart M, Reveiz L, Alvar J (2008) Interventions for Old World cutaneous leishmaniasis. The Cochrane database of systematic reviews 4:111. https:\/\/doi.org\/10.1002\/14651858.CD005067.pub3","journal-title":"The Cochrane database of systematic reviews"},{"key":"788_CR114","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA (2009) Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane database systematic reviews 15 (2 (CD004834)):1-171","DOI":"10.1002\/14651858.CD004834.pub2"},{"key":"788_CR115","unstructured":"DNDi (2019) DNDi - Disease projects - Portfolio. Drugs for Neglected Diseases Initiative. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/. Accessed 7\/11\/2019 2019"},{"key":"788_CR116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","volume":"537","author":"S Khare","year":"2016","unstructured":"Khare S, Nagle AS, Biggart A, Lai YH, Liang F, Davis LC, Barnes SW, Mathison CJN, Myburgh E, Gao M-Y, Gillespie JR, Liu X, Tan JL, Stinson M, Rivera IC, Ballard J, Yeh V, Groessl T, Federe G, Koh HXY, Venable JD, Bursulaya B, Shapiro M, Mishra PK, Spraggon G, Brock A, Mottram JC, Buckner FS, Rao SPS, Wen BG, Walker JR, Tuntland T, Molteni V, Glynne RJ, Supek F (2016) Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 537:229. https:\/\/doi.org\/10.1038\/nature19339\nhttps:\/\/www.nature.com\/articles\/nature19339#supplementary-information","journal-title":"Nature"},{"issue":"6","key":"788_CR117","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1021\/acs.jmedchem.7b01581","volume":"61","author":"AM Thompson","year":"2018","unstructured":"Thompson AM, O\u2019Connor PD, Marshall AJ, Blaser A, Yardley V, Maes L, Gupta S, Launay D, Braillard S, Chatelain E, Wan B, Franzblau SG, Ma Z, Cooper CB, Denny WA (2018) Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): a new Lead for visceral Leishmaniasis. J Med Chem 61(6):2329\u20132352. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01581","journal-title":"J Med Chem"},{"key":"788_CR118","doi-asserted-by":"publisher","unstructured":"Van Bocxlaer K, Caridha D, Black C, Vesely B, Leed S, Sciotti RJ, Wijnant GJ, Yardley V, Braillard S, Mowbray CE, Ioset JR, Croft SL (2019) Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.02.002","DOI":"10.1016\/j.ijpddr.2019.02.002"},{"key":"788_CR119","doi-asserted-by":"publisher","unstructured":"Caridha D, Vesely B, van Bocxlaer K, Arana B, Mowbray CE, Rafati S, Uliana S, Reguera R, Kreishman-Deitrick M, Sciotti R, Buffet P, Croft SL (2019) Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.06.003","DOI":"10.1016\/j.ijpddr.2019.06.003"},{"issue":"6","key":"788_CR120","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.chom.2017.10.020","volume":"22","author":"JH Yang","year":"2017","unstructured":"Yang JH, Bhargava P, McCloskey D, Mao N, Palsson BO, Collins JJ (2017) Antibiotic-induced changes to the host metabolic environment inhibit drug efficacy and alter immune function. Cell Host Microbe 22(6):757\u2013765.e753. https:\/\/doi.org\/10.1016\/j.chom.2017.10.020","journal-title":"Cell Host Microbe"},{"issue":"8","key":"788_CR121","doi-asserted-by":"publisher","first-page":"e3053","DOI":"10.1371\/journal.pntd.0003053","volume":"8","author":"S Burza","year":"2014","unstructured":"Burza S, Mahajan R, Sinha PK, van Griensven J, Pandey K, Lima MA, Sanz MG, Sunyoto T, Kumar S, Mitra G, Kumar R, Verma N, Das P (2014) Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome). PLoS Negl Trop Dis 8(8):e3053. https:\/\/doi.org\/10.1371\/journal.pntd.0003053","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"788_CR122","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5144\/0256-4947.2014.143","volume":"34","author":"AAO Adam","year":"2014","unstructured":"Adam AAO, Dafalla MMM, Mohammed HA, Elamin MY, Younis BM, Elfaki ME, Musa AM, Elhassan AM, Khalil EAG (2014) Visceral leishmaniasis-hepatitis B\/C coinfections: a rising necessity to triage patients for treatment. Ann Saudi Med 34(2):143\u2013146. https:\/\/doi.org\/10.5144\/0256-4947.2014.143","journal-title":"Ann Saudi Med"},{"issue":"11","key":"788_CR123","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.trstmh.2010.07.007","volume":"104","author":"W Hailu","year":"2010","unstructured":"Hailu W, Weldegebreal T, Hurissa Z, Tafes H, Omollo R, Yifru S, Balasegaram M, Hailu A (2010) Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection. Trans R Soc Trop Med Hyg 104(11):706\u2013712. https:\/\/doi.org\/10.1016\/j.trstmh.2010.07.007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"788_CR124","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/cid\/ciy747","volume":"68","author":"J Mbui","year":"2019","unstructured":"Mbui J, Olobo J, Omollo R, Solomos A, Kip AE, Kirigi G, Sagaki P, Kimutai R, Were L, Omollo T, Egondi TW, Wasunna M, Alvar J, Dorlo TPC, Alves F (2019) Pharmacokinetics, safety, and efficacy of an Allometric Miltefosine regimen for the treatment of visceral Leishmaniasis in eastern African children: an open-label, phase II clinical trial. Clin Infect Dis 68(9):1530\u20131538. https:\/\/doi.org\/10.1093\/cid\/ciy747","journal-title":"Clin Infect Dis"},{"issue":"11","key":"788_CR125","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1128\/AAC.44.11.3235-3236.2000","volume":"44","author":"HW Murray","year":"2000","unstructured":"Murray HW (2000) Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral Miltefosine. Antimicrob Agents Chemother 44(11):3235\u20133236","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"788_CR126","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1086\/315268","volume":"181","author":"HW Murray","year":"2000","unstructured":"Murray HW, Delph-Etienne S (2000) Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms. J Infect Dis 181(2):795\u2013799","journal-title":"J Infect Dis"},{"key":"788_CR127","doi-asserted-by":"crossref","unstructured":"Escobar P, Yardley V, Croft SL (2001) Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. (0066\u20134804 (Print))","DOI":"10.1128\/AAC.45.6.1872-1875.2001"},{"issue":"11","key":"788_CR128","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ (2012) Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniaisis. J Antimicrob Chemother 67(11):2576\u20132597","journal-title":"J Antimicrob Chemother"},{"key":"788_CR129","doi-asserted-by":"publisher","unstructured":"Cohen BE (2016) The role of signaling via aqueous pore formation in resistance responses to amphotericin B. 60 (9):5122-5129. https:\/\/doi.org\/10.1128\/AAC.00878-16","DOI":"10.1128\/AAC.00878-16"},{"issue":"9496","key":"788_CR130","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet 366(9496):1577","journal-title":"Lancet"},{"key":"788_CR131","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1155\/2016\/4048235","volume":"2016","author":"L Chavez-Galan","year":"2016","unstructured":"Chavez-Galan L, Vesin D, Martinvalet D, Garcia I (2016) Low dose BCG infection as a model for macrophage activation maintaining cell viability %J journal of immunology. Research 2016:17. https:\/\/doi.org\/10.1155\/2016\/4048235","journal-title":"Research"},{"issue":"4","key":"788_CR132","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0035-9203(03)90093-9","volume":"97","author":"J Convit","year":"2003","unstructured":"Convit J, Ulrich M, Zerpa O, Borges R, Aranzazu N, Valera M, Villarroel H, Zapata Z, Tomedes I (2003) Immunotherapy of American cutaneous leishmaniasis in Venezuela during the period 1990-99. Trans R Soc Trop Med Hyg 97(4):469\u2013472. https:\/\/doi.org\/10.1016\/s0035-9203(03)90093-9","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"788_CR133","doi-asserted-by":"publisher","unstructured":"Musa AM, Khalil EAG, Mahgoub FAE, Elgawi SHH, Modabber F, Elkadaru AEMY, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM Group\/Sudan TLR (2008) Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Trans R Soc Trop Med Hyg 102(1):58\u201363. https:\/\/doi.org\/10.1016\/j.trstmh.2007.08.006","DOI":"10.1016\/j.trstmh.2007.08.006"},{"issue":"6","key":"788_CR134","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2340\/0001555559547549","volume":"59","author":"HA Cohen","year":"1979","unstructured":"Cohen HA (1979) Induction of delayed-type sensitivity to Leishmania parasite in a case of leishmaniasis cutanea diffusa with BCG and cord-factor (Trehalose-6-6\u2032 dimycolate). Acta Derm Venereol 59(6):547\u2013549. https:\/\/doi.org\/10.2340\/0001555559547549","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"788_CR135","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/IAI.48.2.409-416.1985","volume":"48","author":"LE Adinolfi","year":"1985","unstructured":"Adinolfi LE, Bonventre PF, Vander Pas M, Eppstein DA (1985) Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect Immun 48(2):409\u2013416","journal-title":"Infect Immun"},{"issue":"Suppl 1","key":"788_CR136","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/infdis\/167.supplement_1.s13","volume":"167","author":"R Badaro","year":"1993","unstructured":"Badaro R, Johnson WD Jr (1993) The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis. J Infect Dis 167(Suppl 1):S13\u2013S17. https:\/\/doi.org\/10.1093\/infdis\/167.supplement_1.s13","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"788_CR137","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1007\/bf01973598","volume":"13","author":"R Badaro","year":"1994","unstructured":"Badaro R, Nascimento C, Carvalho JS, Badaro F, Russo D, Ho JL, Reed SG, Johnson WD Jr, Jones TC (1994) Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis. Eur J Clin Microbiol Infect Dis 13(Suppl 2):S23\u2013S28. https:\/\/doi.org\/10.1007\/bf01973598","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"788_CR138","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1086\/315082","volume":"180","author":"R Almeida","year":"1999","unstructured":"Almeida R, D'Oliveira A Jr, Machado P, Bacellar O, Ko AI, de Jesus AR, Mobashery N, Brito Santos J, Carvalho EM (1999) Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis. J Infect Dis 180(5):1735\u20131737. https:\/\/doi.org\/10.1086\/315082","journal-title":"J Infect Dis"},{"issue":"10","key":"788_CR139","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1086\/424848","volume":"190","author":"JB Santos","year":"2004","unstructured":"Santos JB, de Jesus AR, Machado PR, Magalhaes A, Salgado K, Carvalho EM, Almeida RP (2004) Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study. J Infect Dis 190(10):1793\u20131796. https:\/\/doi.org\/10.1086\/424848","journal-title":"J Infect Dis"},{"issue":"3","key":"788_CR140","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.actatropica.2004.11.008","volume":"93","author":"HW Murray","year":"2005","unstructured":"Murray HW (2005) Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis. Acta Trop 93(3):295\u2013301. https:\/\/doi.org\/10.1016\/j.actatropica.2004.11.008","journal-title":"Acta Trop"},{"issue":"8","key":"788_CR141","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1128\/iai.73.8.4948-4954.2005","volume":"73","author":"B Flynn","year":"2005","unstructured":"Flynn B, Wang V, Sacks DL, Seder RA, Verthelyi D (2005) Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D\/A oligodeoxynucleotides expressing CpG motifs. Infect Immun 73(8):4948\u20134954. https:\/\/doi.org\/10.1128\/iai.73.8.4948-4954.2005","journal-title":"Infect Immun"},{"issue":"4","key":"788_CR142","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.4049\/jimmunol.166.4.2372","volume":"166","author":"D Verthelyi","year":"2001","unstructured":"Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM (2001) Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J Immunol (Baltimore, Md : 1950) 166(4):2372\u20132377. https:\/\/doi.org\/10.4049\/jimmunol.166.4.2372","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"788_CR143","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1086\/314782","volume":"179","author":"S Buates","year":"1999","unstructured":"Buates S, Matlashewski G (1999) Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 179:1485\u20131494","journal-title":"J Infect Dis"},{"issue":"12","key":"788_CR144","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1086\/518172","volume":"44","author":"I Arevalo","year":"2007","unstructured":"Arevalo I, Tulliano G, Quispe A, Spaeth G, Matlashewski G, Llanos-Cuentas A, Pollack H (2007) Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Clin Infect Dis 44(12):1549\u20131554","journal-title":"Clin Infect Dis"},{"issue":"10","key":"788_CR145","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/429238","volume":"40","author":"C Miranda-Verastegui","year":"2005","unstructured":"Miranda-Verastegui C, Llanos-Cuentas A, Arevalo I, Ward BJ, Matlashewski G (2005) Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin Infect Dis 40(10):1395\u20131403","journal-title":"Clin Infect Dis"},{"issue":"12","key":"788_CR146","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","volume":"142","author":"A Firooz","year":"2006","unstructured":"Firooz A, Khamesipour A, Ghoorchi MH, Nassiri-Kashani M, Eskandari SE, Khatami A, Hooshmand B, Gorouhi F, Rashighi-Firoozabadi M, Dowlati Y (2006) Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis. Arch Dermatol 142(12):1575\u20131579","journal-title":"Arch Dermatol"},{"issue":"11","key":"788_CR147","doi-asserted-by":"publisher","first-page":"e0006854","DOI":"10.1371\/journal.pntd.0006854","volume":"12","author":"R El Hajj","year":"2018","unstructured":"El Hajj R, Bou Youness H, Lachaud L, Bastien P, Masquefa C, Bonnet PA, El Hajj H, Khalifeh I (2018) EAPB0503: an Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica. PLoS Negl Trop Dis 12(11):e0006854. https:\/\/doi.org\/10.1371\/journal.pntd.0006854","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"788_CR148","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1128\/aac.44.6.1494-1498.2000","volume":"44","author":"AC Smith","year":"2000","unstructured":"Smith AC, Yardley V, Rhodes J, Croft SL (2000) Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasis. Antimicrob Agents Chemother 44(6):1494\u20131498. https:\/\/doi.org\/10.1128\/aac.44.6.1494-1498.2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"788_CR149","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1586\/eri.10.64","volume":"8","author":"JE Dalton","year":"2010","unstructured":"Dalton JE, Kaye PM (2010) Immunomodulators: use in combined therapy against leishmaniasis. Expert Rev Anti-Infect Ther 8(7):739\u2013742. https:\/\/doi.org\/10.1586\/eri.10.64","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"6","key":"788_CR150","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1086\/511643","volume":"44","author":"PR Machado","year":"2007","unstructured":"Machado PR, Lessa H, Lessa M, Guimaraes LH, Bang H, Ho JL, Carvalho EM (2007) Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis 44(6):788\u2013793. https:\/\/doi.org\/10.1086\/511643","journal-title":"Clin Infect Dis"},{"issue":"4","key":"788_CR151","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4269\/ajtmh.12-0729","volume":"90","author":"G Brito","year":"2014","unstructured":"Brito G, Dourado M, Polari L, Celestino D, Carvalho LP, Queiroz A, Carvalho EM, Machado PR, Passos S (2014) Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline. Am J Trop Med Hyg 90(4):617\u2013620. https:\/\/doi.org\/10.4269\/ajtmh.12-0729","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"788_CR152","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.4269\/ajtmh.16-0435","volume":"96","author":"G Brito","year":"2017","unstructured":"Brito G, Dourado M, Guimaraes LH, Meireles E, Schriefer A, de Carvalho EM, Machado PRL (2017) Oral pentoxifylline associated with pentavalent antimony: a randomized trial for cutaneous Leishmaniasis. Am J Trop Med Hyg 96(5):1155\u20131159. https:\/\/doi.org\/10.4269\/ajtmh.16-0435","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"788_CR153","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1128\/iai.73.12.7853-7859.2005","volume":"73","author":"DR Faria","year":"2005","unstructured":"Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, Lessa H, Carvalho LP, Romano-Silva MA, de Jesus AR, Carvalho EM, Dutra WO (2005) Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 73(12):7853\u20137859. https:\/\/doi.org\/10.1128\/iai.73.12.7853-7859.2005","journal-title":"Infect Immun"},{"issue":"7","key":"788_CR154","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1365-4632.2006.02867.x","volume":"45","author":"G Sadeghian","year":"2006","unstructured":"Sadeghian G, Nilforoushzadeh MA (2006) Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. Int J Dermatol 45(7):819\u2013821. https:\/\/doi.org\/10.1111\/j.1365-4632.2006.02867.x","journal-title":"Int J Dermatol"},{"issue":"4","key":"788_CR155","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1017\/s003118201600216x","volume":"145","author":"Y Taslimi","year":"2018","unstructured":"Taslimi Y, Zahedifard F, Rafati S (2018) Leishmaniasis and various immunotherapeutic approaches. Parasitology 145(4):497\u2013507. https:\/\/doi.org\/10.1017\/s003118201600216x","journal-title":"Parasitology"},{"key":"788_CR156","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3389\/fimmu.2017.01943","volume":"8","author":"W Adriaensen","year":"2017","unstructured":"Adriaensen W, Dorlo TPC, Vanham G, Kestens L, Kaye PM, van Griensven J (2017) Immunomodulatory therapy of visceral Leishmaniasis in human immunodeficiency virus-coinfected patients. Front Immunol 8:1943. https:\/\/doi.org\/10.3389\/fimmu.2017.01943","journal-title":"Front Immunol"},{"issue":"43","key":"788_CR157","doi-asserted-by":"publisher","first-page":"15551","DOI":"10.1073\/pnas.0505630102","volume":"102","author":"A Sakthianandeswaren","year":"2005","unstructured":"Sakthianandeswaren A, Elso CM, Simpson K, Curtis JM, Kumar B, Speed TP, Handman E, Foote SJ (2005) The wound repair response controls outcome to cutaneous leishmaniasis. Proc Natl Acad Sci U S A 102(43):15551\u201315556","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"788_CR158","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/jac\/dkw012","volume":"71","author":"K Van Bocxlaer","year":"2016","unstructured":"Van Bocxlaer K, Yardley V, Murdan S, Croft SL (2016) Drug permeation and barrier damage in Leishmania-infected mouse skin. J Antimicrob Chemother 71(6):1578\u20131585. https:\/\/doi.org\/10.1093\/jac\/dkw012","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"788_CR159","doi-asserted-by":"publisher","first-page":"e00631","DOI":"10.1128\/aac.00631-18","volume":"62","author":"GJ Wijnant","year":"2018","unstructured":"Wijnant GJ, Van Bocxlaer K, Fortes Francisco A, Yardley V, Harris A, Alavijeh M, Murdan S, Croft SL (2018) Local skin inflammation in cutaneous Leishmaniasis as a source of variable pharmacokinetics and therapeutic efficacy of liposomal amphotericin B. Antimicrob Agents Chemother 62(10):e00631\u2013e00618. https:\/\/doi.org\/10.1128\/aac.00631-18","journal-title":"Antimicrob Agents Chemother"},{"key":"788_CR160","doi-asserted-by":"publisher","unstructured":"Wijnant GJ, Van Bocxlaer K, Yardley V, Harris A, Alavijeh M, Silva-Pedrosa R, Antunes S, Mauricio I, Murdan S, Croft SL (2018) Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome((R)) and AmBisome((R)) in murine cutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist 8 (2):223\u2013228. doi:https:\/\/doi.org\/10.1016\/j.ijpddr.2018.04.001","DOI":"10.1016\/j.ijpddr.2018.04.001"},{"issue":"1","key":"788_CR161","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0166-6851(90)90092-z","volume":"41","author":"GH Coombs","year":"1990","unstructured":"Coombs GH, Wolf CR, Morrison VM, Craft JA (1990) Changes in hepatic xenobiotic-metabolising enzymes in mouse liver following infection with Leishmania donovani. Mol Biochem Parasitol 41(1):17\u201324. https:\/\/doi.org\/10.1016\/0166-6851(90)90092-z","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"788_CR162","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0006-2952(94)90014-0","volume":"47","author":"R Mukhopadhyay","year":"1994","unstructured":"Mukhopadhyay R, Madhubala R (1994) Antileishmanial activity and modification of hepatic xenobiotic metabolizing enzymes in golden hamster by 2(3)-tert-butyl-4-hydroxyanisole following infection with Leishmania donovani. Biochem Pharmacol 47(2):253\u2013256. https:\/\/doi.org\/10.1016\/0006-2952(94)90014-0","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 1","key":"788_CR163","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","volume":"100","author":"H Sindermann","year":"2006","unstructured":"Sindermann H, Engel J (2006) Development of miltefosine as an oral treatment for leishmaniasis. Trans R Soc Trop Med Hyg 100(Suppl 1):S17\u2013S20. https:\/\/doi.org\/10.1016\/j.trstmh.2006.02.010","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"788_CR164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005515","volume":"11","author":"MM Castro","year":"2017","unstructured":"Castro MM, Cossio A, Velasco C, Osorio L (2017) Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: a cohort study. PLoS Negl Trop Dis 11(4):e0005515. https:\/\/doi.org\/10.1371\/journal.pntd.0005515","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"788_CR165","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/jac\/dky014","volume":"73","author":"AA Voak","year":"2018","unstructured":"Voak AA, Standing JF, Sepulveda N, Harris A, Croft SL, Seifert K (2018) Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages. J Antimicrob Chemother 73(5):1314\u20131323. https:\/\/doi.org\/10.1093\/jac\/dky014","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"788_CR166","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrmicro3200","volume":"12","author":"V Dartois","year":"2014","unstructured":"Dartois V (2014) The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol 12(3):159\u2013167. https:\/\/doi.org\/10.1038\/nrmicro3200","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"788_CR167","doi-asserted-by":"publisher","first-page":"120015","DOI":"10.1098\/rsob.120015","volume":"2","author":"CE Bryant","year":"2012","unstructured":"Bryant CE, Monie TP (2012) Mice, men and the relatives: cross-species studies underpin innate immunity. Open Biol 2(4):120015. https:\/\/doi.org\/10.1098\/rsob.120015","journal-title":"Open Biol"},{"issue":"24","key":"788_CR168","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","volume":"24","author":"M Zhao","year":"2016","unstructured":"Zhao M, Lepak AJ, Andes DR (2016) Animal models in the pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents. Bioorg Med Chem 24(24):6390\u20136400. https:\/\/doi.org\/10.1016\/j.bmc.2016.11.008","journal-title":"Bioorg Med Chem"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00788-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-020-00788-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00788-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:26:54Z","timestamp":1615249614000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-020-00788-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":168,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1007\/s00281-020-00788-y","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"25 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}